Temporal shifts of the microbiome associated with antibiotic treatment of purpuric drug eruptions related to epidermal growth factor receptor inhibitors
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
Journal Volume
37
Journal Issue
2
Pages
382
Date Issued
2023-02
Author(s)
Abstract
Epidermal growth factor receptor (EGFR) inhibitors are selective and effective treatments for cancers with relevant mutations. Purpuric drug eruptions are an uncommon but clinically significant dermatological side effect related to EGFR inhibitor use that are associated with positive bacterial cultures and responsive to antibiotic treatment. However, the longitudinal temporal shifts in the skin microbiome that occur before and after antibiotic treatment of purpuric drug eruptions remain largely unknown.
Subjects
CELL LUNG-CANCER
ATOPIC-DERMATITIS
SKIN MICROBIOME
PREVENTION
GEFITINIB
STABILITY
SDGs
Publisher
WILEY
Type
journal article